Peter Frank@peterkimfrank · CEO, ArgoHQ.com
In my day you had to head down to Venice Beach to a walk-in Doc. Might be worth adding some of the "qualifying ailments" that would make you a good candidate for medical cannabis. Would probably help the success rates on completed recommendations if people were able to easily educate themselves before the consultation.
Hua@hua
@peterkimfrank - We've created a quick guide to help patients with educating themselves about qualifying ailments :) https://getmeadow.com/education/... For more in-depth information, we're building a patient resource center: http://patients.getmeadow.com/v1... We believe very strongly in educating the patient throughout the entire lifecycle of getting a… See more
Rick Harrison@rickharrison · Co-Founder, Meadow
@peterkimfrank Thanks, that is a great suggestion! Here are some of the conditions that medical marijuana can help with: Cancer, Anorexia, AIDS/HIV, Chronic Pain, Spasticity, Epilepsy, Arthritis, Glaucoma, Migraine, Anxiety, Depression, Substance abuse Alzheimer’s, Crohn’s Disease, and many more.
Kumar Thangudu@datarade · 2X Saas Founder + Angel Investor
@peterkimfrank @rickharrison wait how does THC help with Crohn's disease. Be specific.
Rick Harrison@rickharrison · Co-Founder, Meadow
@datarade Here's an example study regarding Crohn's - http://www.ncbi.nlm.nih.gov/pubm...
Kumar Thangudu@datarade · 2X Saas Founder + Angel Investor
Rick, What's your email address?
Kumar Thangudu@datarade · 2X Saas Founder + Angel Investor
@rickharrison The study is a weak claim that cannabis helps. "The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases, but this has not been investigated in controlled trials. We performed a prospective trial to determine whether cannabis can induce remission in patients with Crohn's… See more
Rick Harrison@rickharrison · Co-Founder, Meadow
@datarade That was in the background/abstract part of the study justifying the reason of the research. Here is a quote from the conclusion of the study: "Although the primary end point of the study (induction of remission) was not achieved, a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patien… See more
Kumar Thangudu@datarade · 2X Saas Founder + Angel Investor
@rickharrison 23 patients is hardly an acceptable sample size. This study doesn't pass the basic litmus tests of reproducibility. As well, digestive systems are combinatorially complex: https://medium.com/@datarade/you... I'm not trying to be a doryphore. I'm asking you as a fellow YC alum, to strongly reconsider the frequency and intensity with which … See more